Tennessee Clinical Research Center

Nashville, Tennessee 37221

3 studies enrolling now · 95 studies all time

What they study most

Acne, Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Age-Related Atrophy, Alopecia, Androgenetic Alopecia, Arthritis, Psoriatic, Atopic Dermatitis, Atopic Dermatitis (AD), Axillary Hyperhidrosis, Cellulite

Studies at this site

• A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows — Recruiting now
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities — Recruiting now
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp — Recruiting now
• Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis — Completed
• Saypha® VOLUME Lidocaine for Midface Augmentation — Completed
• Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis — Completed
• A Study to Evaluate AI-09 In Participants With Glabellar Lines — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII) — Completed
• Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction. — Running, not enrolling
• Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I — Completed
• Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance — Running, not enrolling
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis — Completed
• A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) — Status unconfirmed
• Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen. — Completed
• Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) — Completed
• Microwave Treatment of Common and Plantar Warts — Status unconfirmed
• Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation — Completed
• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis — Completed
• DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• Treatment for Improvement of Cellulite Appearance Using Form Applicator — Completed
• A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts — Completed
• Treatment of Moderate to Severe Glabellar Lines — Completed
• A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis — Completed
• Safety and Efficacy of Sofwave Treatment to Lift Lax Skin — Completed
• Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma — Stopped early
• Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis — Completed
• Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris — Completed
• A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis — Completed
• A Study of Bermekimab in Patients With Hidradenitis Suppurativa — Completed
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis — Stopped early
• The Trio Laser Module for Hair Removal Treatment — Completed
• Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris — Completed
• A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation — Stopped early
• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation — Completed
• Safety and Effectiveness of PN40082 for Lip Augmentation — Completed
• Use of AAM for Correction of Age Related Volume Deficits in the Face — Completed
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines — Completed
• Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% — Completed
• Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris — Completed
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) — Completed
• Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis — Stopped early
• An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris — Completed
• A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail — Completed
• Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis — Completed
• LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris — Completed